25 Mar 2026 | Basel | 06:00 PM - 08:00 PM CET
Scaling Digital Health Technologies in Clinical Development: Delivering Integrated, Patient Centric Clinical Trials
Sponsored by:Ypsomed
* Applications approved by the Sponsor
About this Meeting
Digital health technologies promise faster, more inclusive, and more efficient clinical trials—but many sponsors still struggle to scale them due to fragmented systems and operational complexity. At the same time, decentralized and hybrid trial models are redefining expectations for patient centricity, making convenience, reduced burden, and flexible participation essential.
This invitation-only executive roundtable will bring together senior pharma leaders and clinical innovators to explore how to transition from isolated digital pilots to fully integrated, patient-first, components of clinical development strategy.
Through a moderated peer discussion, participants will:
- Share practical experiences deploying DHTs across clinical trials
- Examine the organizational and operational barriers limiting scale
- Define what is required to enable sustainable, repeatable integration
- Clarify what sponsors need from digital and device partners to ensure scalability and meaningful patient impact
- Explore how partnerships can enhance patient-centricity across the trial lifecycle
Designed for senior decision-makers, this session offers a confidential forum to exchange insights, challenge assumptions, and shape the future of digitally enabled clinical development.
Space is limited to ensure meaningful discussion and networking.
By applying to this event, you agree to our Terms and Privacy Notice.